Robert Kushner Semaglutide [Ozempic, Novo Nordisk] is the most impactful medication for the treatment of obesity, with 32% of participants losing at least 20% of their initial weight, Robert Kushner, MD, professor of medicine and medical education at Northwestern University Feinberg School of Medicine, Chicago, told Healio
Injecting in the evening near bedtime allows some patients to sleep through the worst of it
A large late-phase clinical trial of the drug for Alzheimer's patients also failed to show that the medication significantly slowed cognitive and functional decline in patients, according to the report
Furthermore, our investigation unveiled the upregulation of EAAT3 in a subset of clinical non-small cell lung cancer (NSCLC) tissues, exhibiting a positive correlation with the P65 protein
Pemvidutide differentiates through favorable body composition data and expansion into alcohol use disorder, potentially carving out a niche if lean mass preservation proves to be a clinically meaningful differentiator